Ayala Pharmaceuticals, Inc. Nonoperating Income (Expense) in USD from Q1 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ayala Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to 2023.
  • Ayala Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$143K, a 14400% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$15.7M, a 21341% decline from 2022.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

Ayala Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$143K -$144K -14400% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$86K -$44K -105% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q3 2022 $1K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$42K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2021 $217K +$218K Feb 1, 2021 Apr 30, 2021 10-Q 2021-06-14
Q1 2020 -$1K Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14

Ayala Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$15.7M -$15.8M -21341% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $74K Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.